Invention Grant
- Patent Title: HCMV vaccine strain
-
Application No.: US16972249Application Date: 2019-06-28
-
Publication No.: US11591373B2Publication Date: 2023-02-28
- Inventor: Bodo Plachter , Christine Zimmermann
- Applicant: Bodo Plachter
- Applicant Address: DE Ansbach
- Assignee: Bodo Plachter
- Current Assignee: Bodo Plachter
- Current Assignee Address: DE Ansbach
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: EP18180863 20180629
- International Application: PCT/EP2019/067355 WO 20190628
- International Announcement: WO2020/002614 WO 20200102
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/245 ; C12N7/00 ; A61K39/00
Abstract:
The present invention relates to nucleic acid molecules encoding a recombinant human cytomegalovirus (HCMV) strain, dense bodies produced by said HCMV strain and preparations of said dense bodies for use in medicine, particularly as a vaccine against HCMV.
Public/Granted literature
- US20210230228A1 HCMV VACCINE STRAIN Public/Granted day:2021-07-29
Information query
